Literature DB >> 9667012

The push-pull action of dopamine on spatial tuning of the monkey retina: the effects of dopaminergic deficiency and selective D1 and D2 receptor ligands on the pattern electroretinogram.

I Bodis-Wollner1, A Tzelepi.   

Abstract

Retinal dopamine depletion in monkeys using either systemic MPTP or 6-OHDA results in attenuated electroretinographic (ERG) responses to peak spatial frequency stimuli. Diverse dopamine receptors have been identified in the primate retina. ERG studies performed using Haloperidol (a mixed antagonist), L-Sulpiride (D2 antagonist) and CY 208-243 (a D1 agonist) cause spatial frequency dependent diverse effects. 'Tuning' of the normal spatial contrast response PERG, was quantified by dividing the amplitude of the response at the peak spatial frequency with the amplitude to the low spatial frequency response yielding a number greater than one. Tuning for the pharmacological experiments was defined by dividing the actual amplitude obtained at the normal peak response with the actual amplitude at the low spatial frequency response. The PERG spatial contrast response function is discussed as the envelope output of retinal ganglion cells or the average or 'equivalent' retinal ganglion cell. However, we postulate the existence of two dopamine sensitive pathways with different weights for two classes of ganglion cells. It is inferred that D1 receptors are primarily affecting the 'surround' organization of ganglion cells with large centers, while D2 post-synaptic receptors contribute to 'center' response amplification of ganglion cells with smaller centers. These inferences are consistent with some lower vertebrate data. It is also inferred that low affinity D2 autoreceptors may be involved in the D1 'surround' pathway. An understanding of the logic performed by retinal D1 and D2 receptors may be useful to discern the functional role of diverse dopamine receptors in DA circuits elsewhere in the CNS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9667012     DOI: 10.1016/s0042-6989(98)00028-5

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  23 in total

1.  Dopamine D2 receptors preferentially regulate the development of light responses of the inner retina.

Authors:  Ning Tian; Hong-ping Xu; Ping Wang
Journal:  Eur J Neurosci       Date:  2014-11-13       Impact factor: 3.386

2.  Spatio-temporal luminance contrast sensitivity and visual backward masking in schizophrenia.

Authors:  Walter L Slaghuis
Journal:  Exp Brain Res       Date:  2004-01-30       Impact factor: 1.972

3.  Influence of dopamine deficiency in early Parkinson's disease on the slow stimulation multifocal-ERG.

Authors:  Anja M Palmowski-Wolfe; Maria Timoner Perez; Stefanie Behnke; Gerhard Fuss; Martin Martziniak; Klaus W Ruprecht
Journal:  Doc Ophthalmol       Date:  2006-06-22       Impact factor: 2.379

4.  Visual and cognitive predictors of driving safety in Parkinson's disease patients.

Authors:  M M Amick; J Grace; B R Ott
Journal:  Arch Clin Neuropsychol       Date:  2007-09-11       Impact factor: 2.813

Review 5.  Frontotemporal and dopaminergic control of idea generation and creative drive.

Authors:  Alice W Flaherty
Journal:  J Comp Neurol       Date:  2005-12-05       Impact factor: 3.215

6.  Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments.

Authors:  Pamela D Butler; Antigona Martinez; John J Foxe; Dongsoo Kim; Vance Zemon; Gail Silipo; Jeannette Mahoney; Marina Shpaner; Maria Jalbrzikowski; Daniel C Javitt
Journal:  Brain       Date:  2006-09-19       Impact factor: 13.501

7.  Potential role of retina as a biomarker for progression of Parkinson's disease.

Authors:  Tian Tian; Xiao-Hua Zhu; Yun-Hai Liu
Journal:  Int J Ophthalmol       Date:  2011-08-18       Impact factor: 1.779

8.  'Gamma' band oscillatory response to chromatic stimuli in volunteers and patients with idiopathic Parkinson's disease.

Authors:  Walter G Sannita; Simone Carozzo; Paolo Orsini; Luciano Domenici; Vittorio Porciatti; Mauro Fioretto; Sergio Garbarino; Ferdinando Sartucci
Journal:  Vision Res       Date:  2009-02-14       Impact factor: 1.886

Review 9.  Retinopathy in Parkinson Disease.

Authors:  Ivan Bodis-Wollner
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

Review 10.  Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS.

Authors:  Michael F Green; Pamela D Butler; Yue Chen; Mark A Geyer; Steven Silverstein; Jonathan K Wynn; Jong H Yoon; Vance Zemon
Journal:  Schizophr Bull       Date:  2008-11-20       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.